The Claim

In older adults with mild cognitive impairment at baseline, statin use is not significantly associated with a reduced risk of dementia or slower cognitive decline over a six-year follow-up period.

Source: Statins, Risk of Dementia and Cognitive Function: Secondary Analysis of the Ginkgo Evaluation of Memory Study (GEMS)

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
67score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Among older adults with mild cognitive impairment, taking statins does not lead to a lower risk of developing dementia or a slower rate of cognitive decline over six years.

See the scientific wording

In older adults with mild cognitive impairment at baseline, statin use shows no significant association with reduced risk of dementia or slower cognitive decline over six years of follow-up.

Why this might work

In people with early memory problems, lowering cholesterol in the brain with statins does not reduce the buildup of harmful protein clumps or calm brain inflammation, so memory continues to decline at the same rate.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Statins, Risk of Dementia and Cognitive Function: Secondary Analysis of the Ginkgo Evaluation of Memory Study (GEMS)

    For older people who already have mild memory issues, taking statins didn’t help prevent dementia or slow memory loss over six years, according to this study.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.